Covalon Technologies Ltd. (COV.V)
| Previous Close | 1.0900 |
| Open | 1.1100 |
| Bid | 0.9800 x 0 |
| Ask | 1.1300 x 0 |
| Day's Range | 1.1100 - 1.1100 |
| 52 Week Range | 0.9600 - 2.0000 |
| Volume | |
| Avg. Volume | 4,206 |
| Market Cap | 27.383M |
| Beta (5Y Monthly) | 0.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1900 |
| Earnings Date | May 28, 2024 - Jun 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireCovalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results
MISSISSAUGA, Ontario, May 22, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, May 29, 2024, at 8:15am ET.
Business WireCovalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
MISSISSAUGA, Ontario, May 17, 2024--INS 2024 Meeting attendees are invited to explore Covalon’s innovative vascular access products first-hand.
Business WireCovalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
MISSISSAUGA, Ontario, March 07, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders ("AGM") held March 6, 2024.
